Logo image of IR

INGERSOLL-RAND INC (IR) Stock Fundamental Analysis

NYSE:IR - New York Stock Exchange, Inc. - US45687V1061 - Common Stock - Currency: USD

76.45  +0.56 (+0.74%)

After market: 76.45 0 (0%)

Fundamental Rating

5

IR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 127 industry peers in the Machinery industry. IR has an average financial health and profitability rating. IR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IR had positive earnings in the past year.
In the past year IR had a positive cash flow from operations.
IR had positive earnings in 4 of the past 5 years.
In the past 5 years IR always reported a positive cash flow from operatings.
IR Yearly Net Income VS EBIT VS OCF VS FCFIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

With a Return On Assets value of 2.87%, IR perfoms like the industry average, outperforming 44.88% of the companies in the same industry.
IR has a Return On Equity of 5.14%. This is comparable to the rest of the industry: IR outperforms 40.16% of its industry peers.
IR has a Return On Invested Capital of 6.91%. This is comparable to the rest of the industry: IR outperforms 51.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IR is below the industry average of 10.56%.
The last Return On Invested Capital (6.91%) for IR is above the 3 year average (6.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.87%
ROE 5.14%
ROIC 6.91%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.33%
ROIC(5y)4.79%
IR Yearly ROA, ROE, ROICIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

IR's Profit Margin of 7.04% is in line compared to the rest of the industry. IR outperforms 57.48% of its industry peers.
In the last couple of years the Profit Margin of IR has grown nicely.
The Operating Margin of IR (19.82%) is better than 88.19% of its industry peers.
IR's Operating Margin has improved in the last couple of years.
IR has a better Gross Margin (43.74%) than 79.53% of its industry peers.
In the last couple of years the Gross Margin of IR has grown nicely.
Industry RankSector Rank
OM 19.82%
PM (TTM) 7.04%
GM 43.74%
OM growth 3Y18.5%
OM growth 5Y9.27%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
IR Yearly Profit, Operating, Gross MarginsIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IR is destroying value.
Compared to 1 year ago, IR has about the same amount of shares outstanding.
The number of shares outstanding for IR has been increased compared to 5 years ago.
IR has a worse debt/assets ratio than last year.
IR Yearly Shares OutstandingIR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
IR Yearly Total Debt VS Total AssetsIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

IR has an Altman-Z score of 3.33. This indicates that IR is financially healthy and has little risk of bankruptcy at the moment.
IR has a Altman-Z score (3.33) which is comparable to the rest of the industry.
IR has a debt to FCF ratio of 3.68. This is a good value and a sign of high solvency as IR would need 3.68 years to pay back of all of its debts.
IR has a Debt to FCF ratio (3.68) which is comparable to the rest of the industry.
IR has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IR (0.47) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.68
Altman-Z 3.33
ROIC/WACC0.71
WACC9.74%
IR Yearly LT Debt VS Equity VS FCFIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

IR has a Current Ratio of 2.29. This indicates that IR is financially healthy and has no problem in meeting its short term obligations.
IR has a Current ratio (2.29) which is in line with its industry peers.
A Quick Ratio of 1.63 indicates that IR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.63, IR is doing good in the industry, outperforming 68.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 1.63
IR Yearly Current Assets VS Current LiabilitesIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

IR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.23%.
IR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.65% yearly.
Looking at the last year, IR shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
Measured over the past years, IR shows a very strong growth in Revenue. The Revenue has been growing by 29.10% on average per year.
EPS 1Y (TTM)-1.23%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-3.61%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%4.58%

3.2 Future

IR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.55% yearly.
Based on estimates for the next years, IR will show a small growth in Revenue. The Revenue will grow by 8.00% on average per year.
EPS Next Y4.71%
EPS Next 2Y7.25%
EPS Next 3Y8.03%
EPS Next 5Y12.55%
Revenue Next Year3.63%
Revenue Next 2Y4.28%
Revenue Next 3Y4.7%
Revenue Next 5Y8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IR Yearly Revenue VS EstimatesIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
IR Yearly EPS VS EstimatesIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.89, which indicates a rather expensive current valuation of IR.
The rest of the industry has a similar Price/Earnings ratio as IR.
IR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.41.
The Price/Forward Earnings ratio is 20.20, which indicates a rather expensive current valuation of IR.
IR's Price/Forward Earnings is on the same level as the industry average.
IR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 33.87.
Industry RankSector Rank
PE 23.89
Fwd PE 20.2
IR Price Earnings VS Forward Price EarningsIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

IR's Enterprise Value to EBITDA is on the same level as the industry average.
IR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 23.76
EV/EBITDA 17.5
IR Per share dataIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IR does not grow enough to justify the current Price/Earnings ratio.
IR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.07
PEG (5Y)1.53
EPS Next 2Y7.25%
EPS Next 3Y8.03%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.10%, IR is not a good candidate for dividend investing.
IR's Dividend Yield is comparable with the industry average which is at 1.91.
With a Dividend Yield of 0.10, IR pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.1%

5.2 History

IR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IR Yearly Dividends per shareIR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

IR pays out 6.23% of its income as dividend. This is a sustainable payout ratio.
DP6.23%
EPS Next 2Y7.25%
EPS Next 3Y8.03%
IR Yearly Income VS Free CF VS DividendIR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
IR Dividend Payout.IR Dividend Payout, showing the Payout Ratio.IR Dividend Payout.PayoutRetained Earnings

INGERSOLL-RAND INC

NYSE:IR (8/11/2025, 8:04:00 PM)

After market: 76.45 0 (0%)

76.45

+0.56 (+0.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners100.59%
Inst Owner Change0.22%
Ins Owners0.17%
Ins Owner Change1.33%
Market Cap30.84B
Analysts77.6
Price Target92.61 (21.14%)
Short Float %3.45%
Short Ratio5.44
Dividend
Industry RankSector Rank
Dividend Yield 0.1%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP6.23%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-14 2025-08-14 (0.02)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.64%
Min EPS beat(2)-4.75%
Max EPS beat(2)-2.53%
EPS beat(4)1
Avg EPS beat(4)-2.56%
Min EPS beat(4)-4.75%
Max EPS beat(4)0.25%
EPS beat(8)5
Avg EPS beat(8)2.46%
EPS beat(12)9
Avg EPS beat(12)5.38%
EPS beat(16)13
Avg EPS beat(16)6.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.44%
Max Revenue beat(2)-0.79%
Revenue beat(4)0
Avg Revenue beat(4)-2.79%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)-0.79%
Revenue beat(8)1
Avg Revenue beat(8)-2.37%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)8
Avg Revenue beat(16)-0.35%
PT rev (1m)1.31%
PT rev (3m)0.67%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)-2.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.63%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE 23.89
Fwd PE 20.2
P/S 4.19
P/FCF 23.76
P/OCF 21.53
P/B 3.06
P/tB N/A
EV/EBITDA 17.5
EPS(TTM)3.2
EY4.19%
EPS(NY)3.78
Fwd EY4.95%
FCF(TTM)3.22
FCFY4.21%
OCF(TTM)3.55
OCFY4.64%
SpS18.25
BVpS25
TBVpS-6.26
PEG (NY)5.07
PEG (5Y)1.53
Profitability
Industry RankSector Rank
ROA 2.87%
ROE 5.14%
ROCE 9%
ROIC 6.91%
ROICexc 7.51%
ROICexgc 48.63%
OM 19.82%
PM (TTM) 7.04%
GM 43.74%
FCFM 17.63%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.33%
ROIC(5y)4.79%
ROICexc(3y)7.12%
ROICexc(5y)5.43%
ROICexgc(3y)46.29%
ROICexgc(5y)35.83%
ROCE(3y)8.25%
ROCE(5y)6.23%
ROICexcg growth 3Y22.68%
ROICexcg growth 5Y21.38%
ROICexc growth 3Y22.68%
ROICexc growth 5Y6.23%
OM growth 3Y18.5%
OM growth 5Y9.27%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.68
Debt/EBITDA 2.45
Cap/Depr 27.44%
Cap/Sales 1.82%
Interest Coverage 5.29
Cash Conversion 73.52%
Profit Quality 250.44%
Current Ratio 2.29
Quick Ratio 1.63
Altman-Z 3.33
F-Score8
WACC9.74%
ROIC/WACC0.71
Cap/Depr(3y)25.25%
Cap/Depr(5y)20.22%
Cap/Sales(3y)1.73%
Cap/Sales(5y)1.5%
Profit Quality(3y)146.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.23%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-3.61%
EPS Next Y4.71%
EPS Next 2Y7.25%
EPS Next 3Y8.03%
EPS Next 5Y12.55%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%4.58%
Revenue Next Year3.63%
Revenue Next 2Y4.28%
Revenue Next 3Y4.7%
Revenue Next 5Y8%
EBIT growth 1Y6.5%
EBIT growth 3Y32.7%
EBIT growth 5Y41.07%
EBIT Next Year16.88%
EBIT Next 3Y10.46%
EBIT Next 5Y12.23%
FCF growth 1Y40.3%
FCF growth 3Y31.28%
FCF growth 5Y32.51%
OCF growth 1Y39.34%
OCF growth 3Y31.41%
OCF growth 5Y32.4%